Literature DB >> 9382374

Severe diabetes associated with protease inhibitor therapy.

F Visnegarwala, K L Krause, D M Musher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9382374     DOI： 10.7326/0003-4819-127-10-199711150-00016

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  22 in total

Review 1.  New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review.

Authors:  E C Lee; S Walmsley; I G Fantus
Journal:  CMAJ       Date:  1999-07-27       Impact factor: 8.262

2.  Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors.

Authors:  Madhu N Rao; Grace A Lee; Carl Grunfeld
Journal:  Am J Infect Dis       Date:  2006-09-30

3.  Protease inhibitor-induced diabetic complications : incidence, management and prevention.

Authors:  Lillian F Lien; Mark N Feinglos
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  The effects of HIV protease inhibitors on carbohydrate and lipid metabolism.

Authors:  Grace A Lee; Madhu N Rao; Carl Grunfeld
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

5.  Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

Authors:  Carl Grunfeld; Donald P Kotler; Donna K Arnett; Julian M Falutz; Steven M Haffner; Paul Hruz; Henry Masur; James B Meigs; Kathleen Mulligan; Peter Reiss; Katherine Samaras
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

Review 6.  Nelfinavir: an update on its use in HIV infection.

Authors:  A Bardsley-Elliot; G L Plosker
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

7.  Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.

Authors:  P Tebas; W G Powderly; S Claxton; D Marin; W Tantisiriwat; S L Teitelbaum; K E Yarasheski
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

8.  Boosting dose ritonavir does not alter peripheral insulin sensitivity in healthy HIV-seronegative volunteers.

Authors:  Steven A Taylor; Grace A Lee; Vivian Y Pao; Jayaranjan Anthonypillai; Francesca T Aweeka; Jean-Marc Schwarz; Kathleen Mulligan; Morris Schambelan; Carl Grunfeld
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

9.  Insulin resistance in HIV protease inhibitor-associated diabetes.

Authors:  K E Yarasheski; P Tebas; C Sigmund; S Dagogo-Jack; A Bohrer; J Turk; P A Halban; P E Cryer; W G Powderly
Journal:  J Acquir Immune Defic Syndr       Date:  1999-07-01       Impact factor: 3.731

Review 10.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.